There is no fixed age cutoff for heart transplants. Most transplant centers once considered 65 the upper limit, but that line has shifted dramatically. In 2023, 845 adults aged 65 and older received heart transplants in the United States, making up about 21% of all adult heart transplants performed that year. The number of transplants in this age group grew 133% between 2012 and 2023. What matters more than your birth certificate is your overall health, and transplant teams now use detailed physical and cognitive assessments to determine candidacy.
Why Age Alone Doesn’t Disqualify You
Transplant medicine has moved away from strict age limits toward a concept called “physiologic age,” which is how well your body actually functions compared to how old you are on paper. A fit, active 72-year-old with no major health problems beyond heart failure may be a better candidate than a 58-year-old with diabetes, kidney disease, and poor mobility. The shift reflects decades of improving surgical techniques, better anti-rejection medications, and growing evidence that older recipients do well after transplant.
That said, Medicare’s original coverage criteria, written in the late 1980s, flagged patients beyond their mid-50s as higher risk and required extra scrutiny for anyone over 50. Those guidelines are largely outdated. Today, many major transplant programs routinely evaluate patients in their late 60s and 70s, and some have transplanted patients older than 75.
Survival Rates for Older Recipients
The survival gap between older and younger heart transplant recipients is smaller than most people expect. An analysis of the U.S. transplant registry found that recipients aged 70 and older had an 87.5% one-year survival rate, compared to 91.1% for those under 60 and 88.4% for those in their 60s. At five years, survival was 77.1% for recipients 70 and older, 78.2% for those 60 to 69, and 80.6% for those under 60.
Those differences are statistically real but practically modest. A roughly 3.5 percentage-point gap in five-year survival between the oldest and youngest groups means that carefully selected older patients still have excellent outcomes. The researchers concluded that transplanting patients 70 and older “can be considered” when those patients are well chosen.
What Risks Look Different in Older Recipients
Older recipients don’t simply face “more risk.” They face different risk. Studies show that older adults who receive heart transplants are more likely to die from cancer or infection than from heart-related causes. Younger recipients, by contrast, are more likely to die from cardiovascular problems or graft failure. This pattern makes sense: immune-suppressing drugs increase cancer risk over time, and older immune systems are less equipped to fight infections even without those drugs.
One unexpected finding is that older recipients actually experience less organ rejection than younger ones. A younger, more active immune system is more aggressive about attacking the transplanted heart, so the very thing that makes older patients more vulnerable to infection may paradoxically protect them from rejection.
How Transplant Teams Evaluate Older Candidates
Instead of relying on a number, transplant programs assess frailty, which is a clinical way of measuring how much reserve your body has to recover from a major surgery. The International Society for Heart and Lung Transplantation recommends evaluating five core areas: unintentional weight loss or muscle wasting, physical weakness, walking speed, exhaustion, and activity level.
In practice, that means your evaluation might include rising from a chair five times without using your hands, a timed walk over about 15 feet, a grip-strength test with a handheld device, and questions about your energy and appetite. Teams also assess cognitive function using screening tests for memory and thinking, and they screen for depression, which can significantly affect recovery.
These assessments aren’t pass-fail in a simple sense. They give the transplant team a picture of whether your body can tolerate the surgery, the intensive recovery period, and the lifelong medication regimen that follows. If frailty is borderline, some programs will put candidates through a rehabilitation program first and reassess.
Older Donor Hearts and Waitlist Times
One practical concern for older candidates is finding a suitable donor heart. Many transplant centers follow a strategy of matching older donor hearts with older recipients, reserving younger donor organs for younger patients unless there’s an urgent need. This approach doesn’t appear to hurt outcomes. When researchers compared recipients who got hearts from donors 55 and older to those who received younger donor hearts, five-year survival was nearly identical: about 77% in both groups after accounting for other differences.
Waitlist times were also similar regardless of donor age, averaging roughly four to six months. However, recipients of older donor hearts did have a higher rate of major cardiac events like heart attacks or the need for additional procedures in the years after transplant. This is something transplant teams weigh when making matching decisions.
How LVADs Compare for Older Patients
For older patients who aren’t transplant candidates, or who face a long wait, a left ventricular assist device (LVAD) is the main alternative. This is a mechanical pump surgically implanted to help the heart move blood. It can serve as a bridge while waiting for a transplant or as a permanent, long-term therapy.
Among patients 65 and older, transplant recipients had significantly better one-year survival than LVAD recipients: 89% versus 67%. Transplant patients also spent less time in the hospital after surgery (9 days versus 15 days on average) and had fewer hospital visits in the months that followed. Both options improved quality of life and physical ability within the first three months, but transplant recipients maintained those improvements more consistently over the following year.
LVADs require substantial daily self-care, including managing an external battery pack, keeping the device’s exit site clean, and monitoring for signs of infection or malfunction. Up to one-third of LVAD recipients continue to experience poor quality of life in the year after implantation, particularly those with other serious health conditions. Patients with greater capacity for self-care tend to do better. For someone who is too frail for transplant, an LVAD may still be worthwhile, but the demands of living with the device are real.
What Actually Determines Candidacy
If you or a family member are wondering whether age rules out a heart transplant, the honest answer is that it depends far less on age than on the full picture of health. The factors that most commonly disqualify older candidates aren’t about the heart at all. They include advanced kidney or liver disease, active or recent cancer, severe lung disease, uncontrolled diabetes, significant cognitive decline, active substance use, and a lack of reliable social support for the long recovery.
Programs also consider whether you can reliably take anti-rejection medications for the rest of your life, attend frequent follow-up appointments (especially in the first year), and maintain the lifestyle changes that protect a transplanted heart. These requirements are the same at any age, but they carry extra weight when evaluating someone in their 70s who may also be managing other chronic conditions.
The clearest takeaway from the data is that being 70 or even 75 does not automatically mean you’re too old. It means your evaluation will be thorough, your other health conditions will be scrutinized carefully, and if you’re selected, your odds of a good outcome are not far behind those of someone decades younger.